SCHEMBL22617781

SCHEMBL22617781

C[C@@H]1[C@H](C)CCC[C@@H]1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25447145 1.00 — —
SCHEMBL19453282 1.00 — —
SCHEMBL18611336 1.00 — —
SCHEMBL18611298 1.00 — —
SCHEMBL18808482 0.92 CA1 (0.38) —
SCHEMBL21788205 0.88 — —
SCHEMBL20886771 0.88 — —
SCHEMBL10289799 0.88 — —
SCHEMBL20886772 0.88 — —
SCHEMBL20886817 0.88 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10822352-B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders ACHILLION PHARMACEUTICALS, INC. (US) 2020-11-03 — — US disclosed
Send feedback